Efficacy and safety of combination therapy of vildagliptin and insuli
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000011828
- Lead Sponsor
- Department of Internal Medicine, School of Medicine, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Type 1 diabetes mellitus 2. Ketosis, DM coma or precoma 3. Severe infection, before or after operation, severe trauma 4. Severe liver dysfunction 5. Patients who have allergy to the medicine used in this study 6. preganant or possible pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c
- Secondary Outcome Measures
Name Time Method